2013
Diagnosing and Characterizing Coronary Artery Disease in Women: Developments in Noninvasive and Invasive Imaging Techniques
Ng VG, Meller S, Shetty S, Lansky AJ. Diagnosing and Characterizing Coronary Artery Disease in Women: Developments in Noninvasive and Invasive Imaging Techniques. Journal Of Cardiovascular Translational Research 2013, 6: 740-751. PMID: 23918630, DOI: 10.1007/s12265-013-9500-1.Peer-Reviewed Original Research
2010
IMPACT OF GENDER ON THE EXTENT OF CORONARY ATHEROSCLEROSIS AND PLAQUE CHARACTERIZATION IN ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE PROSPECT TRIAL
Lansky A, Maehara A, Mintz G, Ng V, Veldhof S, de Bruyne B, McPherson J, Cristea E, Templin B, Parise H, Fahy M, Serruys P, Stone G. IMPACT OF GENDER ON THE EXTENT OF CORONARY ATHEROSCLEROSIS AND PLAQUE CHARACTERIZATION IN ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE PROSPECT TRIAL. Journal Of The American College Of Cardiology 2010, 55: a186.e1738. DOI: 10.1016/s0735-1097(10)61739-1.Peer-Reviewed Original Research
2009
Impact of Gender and Antithrombin Strategy on Early and Late Clinical Outcomes in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the ACUITY Trial)
Lansky AJ, Mehran R, Cristea E, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Stone GW. Impact of Gender and Antithrombin Strategy on Early and Late Clinical Outcomes in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the ACUITY Trial). The American Journal Of Cardiology 2009, 103: 1196-1203. PMID: 19406258, DOI: 10.1016/j.amjcard.2009.01.030.Peer-Reviewed Original ResearchMeSH KeywordsAcute Coronary SyndromeAdultAge FactorsAgedAged, 80 and overAngioplasty, Balloon, CoronaryAnticoagulantsAntithrombinsCause of DeathDose-Response Relationship, DrugDrug Administration ScheduleDrug Therapy, CombinationElectrocardiographyEnoxaparinFemaleFollow-Up StudiesHeparinHirudinsHumansMaleMiddle AgedPeptide FragmentsPlatelet Glycoprotein GPIIb-IIIa ComplexProbabilityProportional Hazards ModelsRecombinant ProteinsReference ValuesRisk AssessmentSeverity of Illness IndexSex FactorsSurvival AnalysisTime FactorsTreatment OutcomeConceptsGlycoprotein IIb/IIIa inhibitorsElevation acute coronary syndromePercutaneous coronary interventionAcute coronary syndromeComposite ischemiaNet clinical outcomeMajor bleedingCoronary syndromeClinical outcomesNet clinical adverse eventsIIb/IIIa inhibitorsLate clinical outcomesCoronary artery bypassClinical adverse eventsImpact of genderACUITY trialBivalirudin monotherapyAntithrombotic therapyArtery bypassNon–STAdverse eventsAntithrombotic strategiesCoronary interventionIschemiaBivalirudin
2003
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, Mintz GS, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. Journal Of Invasive Cardiology 2003, 15: 18-22. PMID: 12499523.Peer-Reviewed Original ResearchConceptsContrast-induced nephropathyChronic renal failureOne-year mortalityIndependent predictorsPercutaneous interventionDiabetes mellitusClinical outcomesFemale genderMultivariate analysisOne-year clinical eventsNYHA IV classSevere heart failurePercutaneous coronary interventionImpact of genderCoronary interventionRenal failureHeart failureMale patientsCIN developmentClinical eventsPatientsMortalityMellitusNephropathySignificant gender differences
2002
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention
Iakovou I, Dangas G, Lansky A, Negoita M, Hjazi I, Ashby D, Costantini C, Guiry M, Brandwein R, Losquadro M, Forman J, Moses J, Stone G, Leon M, Mehran R. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. Journal Of The American College Of Cardiology 2002, 39: 2. DOI: 10.1016/s0735-1097(02)80004-3.Peer-Reviewed Original Research